| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 09/29/2004 | EP1461443A2 Carbohydrate-associated proteins |
| 09/29/2004 | EP1461421A2 A method for the establishment of a pluripotent human blastocyst-derived stem cell line |
| 09/29/2004 | EP1461361A1 Negatively charged polysaccharide derivable from aloe vera |
| 09/29/2004 | EP1461358A1 Ifnar2 muteins, their production and use |
| 09/29/2004 | EP1461339A2 Spiroazacyclic compounds as monoamine receptor modulators |
| 09/29/2004 | EP1461337A1 Pyrido[2,1-a]isoquinoline derivatives as dpp-iv inhibitors |
| 09/29/2004 | EP1461336A2 1-alkyl-1-azoniabicyclo (2.2.2) octane carbamate derivatives and their use as muscarinic receptor antagonists |
| 09/29/2004 | EP1461334A2 Pyrazole derived kinase inhibitors |
| 09/29/2004 | EP1461323A2 Compounds for the treatment of metabolic disorders |
| 09/29/2004 | EP1461321A1 3,4-di-substituted pyridazinediones as cxc chemokine receptor antagonists |
| 09/29/2004 | EP1461313A1 Human adam-10 inhibitors |
| 09/29/2004 | EP1461122A2 Treatment of genitourinary tract disorders |
| 09/29/2004 | EP1461080A2 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| 09/29/2004 | EP1461067A1 Compositions and method for treating hepatitis virus infection |
| 09/29/2004 | EP1461054A2 Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation |
| 09/29/2004 | EP1461047A1 Compositions and methods for animal treatment |
| 09/29/2004 | EP1461040A1 Succinic acid salts of 5,8,14-triazatetracyclo[10.3.1.0 2,11 .0 4,9 ]-hexadeca-2(11),3,5,7,9,-pentaene and pharmaceutical compositions thereof |
| 09/29/2004 | EP1461034A1 Substituted imidazolidines, method for the production thereof, use thereof as a drug or for diagnosis, and drug containing substituted imidazolidines |
| 09/29/2004 | EP1461021A1 Transdermal drug delivery system of strychnine, brucine, securinine and their salts |
| 09/29/2004 | EP1460995A1 Transdermal transport of compounds |
| 09/29/2004 | EP1389202B1 2,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonists |
| 09/29/2004 | EP1385874A4 Alpha conotoxin peptides with analgesic properties |
| 09/29/2004 | EP1303527B1 Matrix metalloproteinase inhibitors |
| 09/29/2004 | EP1254143B1 Lipid-based drug delivery systems |
| 09/29/2004 | EP1210320B1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha |
| 09/29/2004 | EP1202959B1 Aminobenzophenones as inhibitors of il-1-beta and tnf-alpha |
| 09/29/2004 | EP1202957B1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha |
| 09/29/2004 | EP1200400B1 Substituted pyrrolidin-2,3,4-trion derivatives useful as nmda-receptor antagonists |
| 09/29/2004 | EP1189905B1 Substituted heterocycle fused gamma-carbolines |
| 09/29/2004 | EP1189881B1 Propanoic acid derivatives that inhibit the binding of integrins to their receptors |
| 09/29/2004 | EP1181278B1 Cyclic amine derivatives and their uses |
| 09/29/2004 | EP1169339B1 Macrocyclic peptides inhibiting the hepatitis c virus ns3 protease |
| 09/29/2004 | EP1169302B1 N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists |
| 09/29/2004 | EP1153015B1 Pyrimidine-2,4,6-triones as inhibitors of matrix metalloproteinases |
| 09/29/2004 | EP1019040B1 Aryl ureas for the treatment of inflammatory or immunomodulatory diseases |
| 09/29/2004 | EP0989848B1 Film-coated tablet for improved upper gastrointestinal tract safety |
| 09/29/2004 | EP0969813B1 Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker |
| 09/29/2004 | EP0878199B1 Natural tea comprising alder and mountain ash extracts for treating the effects of alcoholic drinks |
| 09/29/2004 | EP0627925B1 Trypsin inhibitors |
| 09/29/2004 | CN1533399A 免疫调节肽 Immunomodulatory peptides |
| 09/29/2004 | CN1533392A Pyrazolopgrimidinone derivatives having PED 7 inhibitory activity |
| 09/29/2004 | CN1533391A Tricyclic compounds and their uses |
| 09/29/2004 | CN1533387A 1-phenysulfonyl-1,3-dihydro-2H-indole-2-one derivatives, their preparation and their therapeutic use |
| 09/29/2004 | CN1533382A 哌嗪衍生物 Piperazine derivatives |
| 09/29/2004 | CN1533374A Substitutled cyclohexane-1,4-diamine derivatives |
| 09/29/2004 | CN1533284A Use of biologically active HIV-1 Tat, fragments or derivatives thereof for preventing or therapeutic vaccination and/or treating other diseases |
| 09/29/2004 | CN1533280A Carbohydrate modifying agent and drinks containing the same |
| 09/29/2004 | CN1533279A Organo-phosphorous compounds for activating gamma/delta T-cells |
| 09/29/2004 | CN1533276A Use of thiazole derivatives for preparing medicine for protecting mitochondria |
| 09/29/2004 | CN1533271A 5-amino levulic acid as photosensitizer in ligh chemical therapy and cpmbination of its ester and another photosensitizer, and their use in therapy |
| 09/29/2004 | CN1533270A Oral administered dosage form of GABA anolog prodrugs having reduced toxicity |
| 09/29/2004 | CN1532285A Methanol yeast Pichia pastoris produce the augmenters of liver regeneration and its mutant. |
| 09/29/2004 | CN1532206A Active fragment of thymosin alphal and its polyethylene glycol derivatives |
| 09/29/2004 | CN1532196A Quinic compound containing quaternary ammonium group and its preparation and medicina use |
| 09/29/2004 | CN1531963A Medicinal composition for treating hyperhydrochloria, its preparing method and use |
| 09/29/2004 | CN1531962A Medicine for treating intestinal obstruction and its preparing method |
| 09/29/2004 | CN1531958A Medicine for treating cirrhosis, liver ascites and liver cancer and preparing method |
| 09/29/2004 | CN1531956A Chinese medicine compound composition and its preparing method and use |
| 09/29/2004 | CN1531952A 强身胶囊 Physical Capsules |
| 09/29/2004 | CN1531947A Xiangbei notoginseng powder for treating gastric ulcer |
| 09/29/2004 | CN1531942A Digestion promoting and stomach strengthening pill |
| 09/29/2004 | CN1531933A Medicinal composition for treating hepatitis |
| 09/29/2004 | CN1531922A Limonene soft capsule oral medicine for treating biliary tract disease and its preparing process |
| 09/29/2004 | CN1168827C Nucleotide specific to O-antigen of shigella boydii 7 |
| 09/29/2004 | CN1168728C Pyrrolo-isoquinoline and tetrahydropyrrolko-isoquinoline derivatives and their use as mediators of 5-HT7 reactor |
| 09/29/2004 | CN1168720C Aryl alkanoylpyridazines compounds |
| 09/29/2004 | CN1168719C 6-phenylpyridyl-2-amine derivatives and pharmaceutical composition and use |
| 09/29/2004 | CN1168709C Alpha-hydroxy, amino and fluoro derivatives of beta-sulphenyl hdyroxamic acids matrix metalloproteinase inhibitors |
| 09/29/2004 | CN1168499C Medicament for optimising mucosal viscosity and stimulating intestinal function |
| 09/29/2004 | CN1168491C Tonic beverage for athlete |
| 09/29/2004 | CN1168490C Health-care products extracted from ostrich blood, penis orchis |
| 09/29/2004 | CN1168487C Medicine for treating diarrhea |
| 09/29/2004 | CN1168486C Medicine composition with immunogulating and digestion-promoting functions |
| 09/29/2004 | CN1168482C Chinese medicine composition for treating enteritis |
| 09/29/2004 | CN1168478C Chinese herbal medicine for treating hepatitis A |
| 09/29/2004 | CN1168475C Chinese herbal medicine composition for treating pyloric spirobacterium infected gastropathy and its production process |
| 09/29/2004 | CN1168471C Medicine for treating recurrent aphtha and eczema |
| 09/29/2004 | CN1168464C Traditional Chinese medicine for treating hepatitis |
| 09/29/2004 | CN1168461C Buccal tablet with pharynx purging and intestine lubricating action |
| 09/29/2004 | CN1168460C Chinese medicine health product with adjusting action of enterogastric function |
| 09/29/2004 | CN1168459C Chinese medicine for treating icterhepatitis |
| 09/29/2004 | CN1168453C Application of N-acetyl-D-aminoglucose in preparing medicine to prevent anjd treat motion sickness |
| 09/29/2004 | CN1168436C Antiplaque oral composition and its use |
| 09/28/2004 | US6797713 1,4 substituted piperazines, 1,4 substituted piperidines, and 1-substituted,4-alkylidenyl piperidine compounds; dual acting molecules having both leukotriene inhibition properties |
| 09/28/2004 | US6797709 Sexual disorders |
| 09/28/2004 | US6797499 Isolated human dehydrogenases, nucleic acid molecules encoding these human dehydrogenases, and uses thereof |
| 09/28/2004 | US6797489 PP14 fusion proteins and methods for making and using the same |
| 09/28/2004 | US6797291 Comprises protective lipid coating (hydrogenated oils) for choline chloride or lysine hydrochloride; ruminant feeds |
| 09/28/2004 | US6797268 Pharmaceutical composition useful in the treatment of peptic ulcers |
| 09/28/2004 | US6797266 Probiotic composition containing Lactobacillus casei strain ATCC PTA-3945 |
| 09/28/2004 | CA2301354C Low temperature expression cdnas encoding fructan synthesizing enzymes and method of isolating the same |
| 09/28/2004 | CA2299013C Neuropeptide y antagonists |
| 09/28/2004 | CA2167268C Anti-angiogenic compositions and methods of use |
| 09/28/2004 | CA2162557C Conserved motif of hepatitis c virus e2/ns1 region |
| 09/23/2004 | WO2004080968A1 6-substituted nicotinamide derivatives as opioid receptor antagonists |
| 09/23/2004 | WO2004080961A2 Crystalline and amorphous solids of pantoprazole and processes for their preparation |
| 09/23/2004 | WO2004080933A2 Isolation of lutein from alfalfa |
| 09/23/2004 | WO2004080487A1 Preventive or remedy for teeth grinding |
| 09/23/2004 | WO2004080485A1 Preventive/remedy for diseases in upper digestive tract |
| 09/23/2004 | WO2004080453A1 Antihepatitis c virus agent and anti-hiv agent |